State of Play in Alzheimer's Disease Genetics.
暂无分享,去创建一个
[1] M. Ewers,et al. Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis , 2017, Front. Aging Neurosci..
[2] R. Ransohoff,et al. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease , 2017, The Journal of Neuroscience.
[3] Shannon L. Risacher,et al. The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism , 2016, Alzheimer's & dementia.
[4] Asha A. Nair,et al. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression , 2016, Alzheimer's & Dementia.
[5] Alzheimer's Disease Neuroimaging Initiative,et al. The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer’s Disease , 2016, Molecular Neurobiology.
[6] J. Borén,et al. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele , 2016, Brain Research.
[7] Christiane Reitz,et al. Toward precision medicine in Alzheimer's disease. , 2016, Annals of translational medicine.
[8] Fang Hao,et al. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1 , 2015, Molecular Neurobiology.
[9] T. Jiang,et al. TREM2 p.H157Y Variant and the Risk of Alzheimer's Disease: A Meta-Analysis Involving 14,510 Subjects. , 2016, Current neurovascular research.
[10] G. Schellenberg,et al. Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease , 2016, PLoS genetics.
[11] Michelle K. Lupton,et al. ABCA7 p.G215S as potential protective factor for Alzheimer's disease , 2016, Neurobiology of Aging.
[12] C. Caltagirone,et al. Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer’s disease , 2016, European Archives of Psychiatry and Clinical Neuroscience.
[13] Alzheimer's Disease Neuroimaging Initiative,et al. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum , 2016, Molecular Neurobiology.
[14] Alzheimer's Disease Neuroimaging Initiative,et al. Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders , 2016, Molecular Neurobiology.
[15] Xu Ma,et al. The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer’s disease in Caucasian, and Asian populations , 2016, Neuroscience Letters.
[16] Kristel Sleegers,et al. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond , 2016, The Lancet Neurology.
[17] S. Mai. Editorial (Thematic Issue: Towards New Approaches in Alzheimer’s Research and Alzheimer’s Disease) , 2016 .
[18] C. Broeckhoven,et al. Molecular genetics of early-onset Alzheimer's disease revisited , 2016, Alzheimer's & Dementia.
[19] Michael Lutz,et al. Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease , 2016, Alzheimer's & Dementia.
[20] L. Tan,et al. A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese , 2016, Neurobiology of Aging.
[21] Wei Zhang,et al. FERMT2 rs17125944 polymorphism with Alzheimer's disease risk: a replication and meta-analysis , 2016, Oncotarget.
[22] Sterling C. Johnson,et al. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts , 2016, Scientific Reports.
[23] L. Tan,et al. Impact of SORL1 genetic variations on MRI markers in non-demented elders , 2016, Oncotarget.
[24] Alison M. Goate,et al. Alzheimer’s Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci , 2016, PloS one.
[25] D. Holtzman,et al. TREM2 Function in Alzheimer's Disease and Neurodegeneration. , 2016, ACS chemical neuroscience.
[26] L. Tan,et al. SORL1 Is Associated with the Risk of Late-Onset Alzheimer’s Disease: a Replication Study and Meta-Analyses , 2016, Molecular Neurobiology.
[27] I. Gozes,et al. Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer’s Disease , 2016, Journal of Molecular Neuroscience.
[28] J. Jia,et al. An Overview of Genome-Wide Association Studies in Alzheimer’s Disease , 2016, Neuroscience Bulletin.
[29] L. Tan,et al. TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice , 2016, Molecular Neurobiology.
[30] Keith A. Johnson,et al. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts , 2016, Molecular Neurobiology.
[31] Christoph Lange,et al. Family-based Association Analyses of Imputed Genotypes Reveal Genome-Wide Significant Association of Alzheimer’s disease with OSBPL6, PTPRG and PDCL3 , 2015, Molecular Psychiatry.
[32] P. Deyn,et al. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42 , 2015, Alzheimer's & Dementia.
[33] C. Jack,et al. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern , 2015, Alzheimer's & Dementia.
[34] R. Sims,et al. Defining the Genetic Architecture of Alzheimer's Disease: Where Next? , 2015, Neurodegenerative Diseases.
[35] Florence F. Roussotte,et al. Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion , 2015, Alzheimer's & Dementia.
[36] Jochen Herms,et al. η-Secretase processing of APP inhibits neuronal activity in the hippocampus , 2015, Nature.
[37] Christine Van Broeckhoven,et al. The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.
[38] R. Wilson,et al. Alzheimer's disease: rare variants with large effect sizes. , 2015, Current opinion in genetics & development.
[39] Chen Zhang,et al. PLD3 in Alzheimer’s Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses , 2015, Molecular Neurobiology.
[40] T. E. Purwata,et al. Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials , 2015, CNS Drugs.
[41] R. Green,et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans , 2015, Alzheimer's & Dementia.
[42] M. Pericak-Vance,et al. F-box/LRR-repeat protein 7 is genetically associated with Alzheimer’s disease , 2015, Annals of clinical and translational neurology.
[43] F. Zhang,et al. An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer’s disease in the Han Chinese population , 2015, Neuropsychiatric disease and treatment.
[44] P. S. St George-Hyslop,et al. Rare coding mutations identified by sequencing of Alzheimer disease genome‐wide association studies loci , 2015, Annals of neurology.
[45] C. Jack,et al. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. , 2015, JAMA neurology.
[46] Steven D. Edland,et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. , 2015, Cell stem cell.
[47] R. Ransohoff,et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.
[48] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[49] L. Lue,et al. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex , 2015, Neurobiology of Aging.
[50] Yufeng Shen,et al. Coding mutations in SORL1 and Alzheimer disease , 2015, Annals of neurology.
[51] Huadong Zhou,et al. Genetic Association Between APP, ADAM10 Gene Polymorphism, and Sporadic Alzheimer’s Disease in the Chinese Population , 2015, Neurotoxicity Research.
[52] A. Goate,et al. Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.
[53] J. Gallacher,et al. Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.
[54] W. M. van der Flier,et al. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. , 2014, Human molecular genetics.
[55] A. Hofman,et al. A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly , 2014, Molecular Psychiatry.
[56] Y. Liu,et al. Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease , 2014, PLoS ONE.
[57] C. Cruchaga,et al. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant , 2014, Neurobiology of Aging.
[58] J. Haines,et al. A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death , 2014, Nature Medicine.
[59] Terry E. Goldberg,et al. Extension and refinement of the predictive value of different classes of markers in ADNI: Four-year follow-up data , 2014, Alzheimer's & Dementia.
[60] Timothy J. Hohman,et al. Genetic modification of the relationship between phosphorylated tau and neurodegeneration , 2014, Alzheimer's & Dementia.
[61] Michael W. Weiner,et al. Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure , 2014, Neurobiology of Aging.
[62] K. Lunetta,et al. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans , 2014, Alzheimer's & Dementia.
[63] Yu-ying Zhou,et al. Clinical and Neuroimaging Characterization of Chinese Dementia Patients with PSEN1 and PSEN2 Mutations , 2014, Dementia and Geriatric Cognitive Disorders.
[64] B. Tang,et al. Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China , 2014, Neurobiology of Aging.
[65] Carlos Cruchaga,et al. Identification of rare variants in Alzheimer’s disease , 2014, Front. Genet..
[66] K. Lunetta,et al. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation , 2014, Annals of neurology.
[67] Shannon L. Risacher,et al. Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm , 2014, Bioinform..
[68] Timothy J. Hohman,et al. Genetic variation modifies risk for neurodegeneration based on biomarker status , 2014, Front. Aging Neurosci..
[69] E. Golemis,et al. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease , 2014, Oncoscience.
[70] A. Goate,et al. Alzheimer’s Disease Genetics: From the Bench to the Clinic , 2014, Neuron.
[71] L. Tan,et al. Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals , 2014, Neurobiology of Aging.
[72] L. Tan,et al. PLD3 in Alzheimer’s Disease , 2014, Molecular Neurobiology.
[73] D. Holtzman,et al. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 , 2014, Molecular Neurodegeneration.
[74] A. Saykin,et al. APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[75] L. Tan,et al. The Role of SORL1 in Alzheimer’s Disease , 2014, Molecular Neurobiology.
[76] Florence F. Roussotte,et al. Combined Effects of Alzheimer Risk Variants in the CLU and ApoE Genes on Ventricular Expansion Patterns in the Elderly , 2014, The Journal of Neuroscience.
[77] L. Tan,et al. CR1 in Alzheimer's Disease , 2014, Molecular Neurobiology.
[78] Marina Barysheva,et al. A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations , 2014, Human brain mapping.
[79] L. Tan,et al. Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese , 2014, Neurobiology of Aging.
[80] N. Andreasen,et al. Pathways to Alzheimer's disease , 2014, Journal of internal medicine.
[81] Timothy J. Hohman,et al. Interactions between GSK3β and amyloid genes explain variance in amyloid burden , 2014, Neurobiology of Aging.
[82] L. Tan,et al. Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese , 2014, Neurobiology of Aging.
[83] Karmen K. Yoder,et al. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status , 2014, Alzheimer's & Dementia.
[84] Michael W. Weiner,et al. A single nucleotide polymorphism associated with reduced alcohol intake in the RASGRF2 gene predicts larger cortical volumes but faster longitudinal ventricular expansion in the elderly , 2013, Front. Aging Neurosci..
[85] Teng Jiang,et al. Application of next-generation sequencing technologies in Neurology. , 2013, Annals of translational medicine.
[86] D. Fardo,et al. ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status , 2013, Neuroscience Letters.
[87] Magda Tsolaki,et al. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. , 2013, Journal of Alzheimer's disease : JAD.
[88] John Hardy,et al. SnapShot: Genetics of Alzheimer’s Disease , 2013, Cell.
[89] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[90] P. Thompson,et al. TREM2 and neurodegenerative disease. , 2013, The New England journal of medicine.
[91] D. Hibar,et al. TREM2 Risk Variant and Loss of Brain Tissue , 2013 .
[92] R. Tanzi,et al. ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.
[93] P. Thompson,et al. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers , 2013, Brain Imaging and Behavior.
[94] Yuan Tian,et al. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy , 2013, Proceedings of the National Academy of Sciences.
[95] K. Shpanskaya,et al. Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth , 2013, NeuroImage.
[96] Jason J. Corneveaux,et al. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. , 2013, JAMA neurology.
[97] Nan Hu,et al. CD33 in Alzheimer's Disease , 2013, Molecular Neurobiology.
[98] G. Landreth,et al. Evidence for impaired amyloid β clearance in Alzheimer's disease , 2013, Alzheimer's Research & Therapy.
[99] Richard J. Caselli,et al. Association between an Alzheimer’s Disease-Related Index and APOE ε4 Gene Dose , 2013, PloS one.
[100] Keith A. Johnson,et al. CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology , 2013, Nature Neuroscience.
[101] O. Combarros,et al. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease , 2013, Journal of Neural Transmission.
[102] A. Shah,et al. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions , 2013, Proceedings of the National Academy of Sciences.
[103] K. Lunetta,et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. , 2013, JAMA.
[104] T. Lehtimäki,et al. Genetic Loci Associated with Alzheimer’s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort , 2013, PloS one.
[105] M. Owen,et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.
[106] C. Jack,et al. Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity , 2013, Proceedings of the National Academy of Sciences.
[107] C. Jack,et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) , 2013, Front. Aging Neurosci..
[108] Michael W. Weiner,et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study , 2013, Molecular Psychiatry.
[109] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[110] A. Goate,et al. Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains , 2012, PloS one.
[111] H. Soininen,et al. APOE4 predicts amyloid-β in cortical brain biopsy but not idiopathic normal pressure hydrocephalus , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[112] A. Goate,et al. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort , 2012, Alzheimer's Research & Therapy.
[113] A. Fagan,et al. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. , 2012, Human molecular genetics.
[114] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[115] M A Pericak-Vance,et al. Genome-wide association study of Alzheimer's disease , 2012, Translational Psychiatry.
[116] Qingli Xiao,et al. Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis* , 2012, The Journal of Biological Chemistry.
[117] Shannon L. Risacher,et al. A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort , 2012, NeuroImage.
[118] B. de Strooper,et al. The mechanism of γ-Secretase dysfunction in familial Alzheimer disease , 2012, The EMBO journal.
[119] B Croisile,et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease , 2012, Molecular Psychiatry.
[120] M Mancuso,et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease , 2012, Molecular Psychiatry.
[121] John Hardy,et al. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE , 2012, Neurobiology of Aging.
[122] Jennifer Williamson,et al. Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families , 2012, PloS one.
[123] Angelyn R. Lao,et al. Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease , 2012, The EMBO journal.
[124] Robert C Green,et al. A comprehensive genetic association study of Alzheimer disease in African Americans. , 2011, Archives of neurology.
[125] Raymond Scott Turner,et al. Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study , 2011, Neurobiology of Aging.
[126] L. Tan,et al. Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population , 2011, Brain Research.
[127] Alzheimer's Disease Neuroimaging Initiative,et al. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease , 2011, Molecular Psychiatry.
[128] Eric M Reiman,et al. Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast , 2011, Science.
[129] Karmen K. Yoder,et al. Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort , 2011, Brain Imaging and Behavior.
[130] Michelle K. Lupton,et al. Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms , 2011, Molecular Psychiatry.
[131] A. Fagan,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[132] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[133] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[134] Hilkka Soininen,et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations , 2011, Neurobiology of Aging.
[135] Holly Soares,et al. Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease , 2011, PloS one.
[136] A. Fagan,et al. Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease , 2011, PloS one.
[137] E. Wijsman,et al. Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.
[138] L. Tan,et al. Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese , 2011, Journal of the Neurological Sciences.
[139] S. Potkin,et al. Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort , 2010, Neurology.
[140] L. Tan,et al. Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[141] G. Schellenberg,et al. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study , 2010, BMC neurology.
[142] M. Owen,et al. Distribution and Expression of Picalm in Alzheimer Disease , 2010, Journal of neuropathology and experimental neurology.
[143] C. Masters,et al. Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.
[144] E. Kremmer,et al. ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons , 2010, The EMBO journal.
[145] J. Gilbert,et al. Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities , 2010, PLoS genetics.
[146] Jason J. Corneveaux,et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. , 2010, Human molecular genetics.
[147] M Krawczak,et al. Examination of the current top candidate genes for AD in a genome-wide association study , 2010, Molecular Psychiatry.
[148] R. Desikan,et al. Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.
[149] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[150] James B Leverenz,et al. Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. , 2010, Brain : a journal of neurology.
[151] B. Bergmans,et al. γ-secretases: from cell biology to therapeutic strategies , 2010, The Lancet Neurology.
[152] Nick C Fox,et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease , 2009, Neurology.
[153] Dong Liu,et al. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35) , 2009, Immunopharmacology and immunotoxicology.
[154] K. Elliott,et al. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. , 2009, Human molecular genetics.
[155] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[156] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[157] M. Gobbi,et al. A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis , 2009, Science.
[158] L. Daviet,et al. The membrane-tubulating potential of amphiphysin 2/BIN1 is dependent on the microtubule-binding cytoplasmic linker protein 170 (CLIP-170). , 2009, European journal of cell biology.
[159] V. Pankratz,et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.
[160] Eden R Martin,et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.
[161] S E Poduslo,et al. Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[162] Christoph Lange,et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.
[163] E. Koo,et al. Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.
[164] M. Mattson,et al. Clathrin Assembly Protein AP180 and CALM Differentially Control Axogenesis and Dendrite Outgrowth in Embryonic Hippocampal Neurons , 2008, The Journal of Neuroscience.
[165] A. Hill,et al. ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro , 2008, Journal of neurochemistry.
[166] Q. Ding,et al. Comparative proteomic analysis of brains of naturally aging mice , 2008, Neuroscience.
[167] M. Mattson,et al. Evidence for CALM in Directing VAMP2 Trafficking , 2008, Traffic.
[168] Rebecca F. Halperin,et al. Sorl1 as an Alzheimer’s Disease Predisposition Gene? , 2007, Neurodegenerative Diseases.
[169] K. Sleegers,et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. , 2007, Archives of neurology.
[170] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[171] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[172] M. Gill,et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.
[173] K. Lunetta,et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.
[174] K. Sleegers,et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. , 2006, Brain : a journal of neurology.
[175] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[176] D. Holtzman,et al. Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model , 2005, The Journal of Neuroscience.
[177] Bruce J Aronow,et al. ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition Evidence that ApoE Regulates Extracellular Aβ Metabolism In Vivo , 2004, Neuron.
[178] A. Goate,et al. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe , 2003, Human mutation.
[179] M. Mattson,et al. Heterogeneity of endocytic proteins: distribution of clathrin adaptor proteins in neurons and glia , 2003, Neuroscience.
[180] J. Schmitz,et al. γ-Secretase Activity Is Associated with a Conformational Change of Nicastrin* , 2003, The Journal of Biological Chemistry.
[181] Bruce J Aronow,et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[182] M. Picciotto,et al. Decreased Synaptic Vesicle Recycling Efficiency and Cognitive Deficits in Amphiphysin 1 Knockout Mice , 2002, Neuron.
[183] H. Bellen,et al. Synaptic Vesicle Size and Number Are Regulated by a Clathrin Adaptor Protein Required for Endocytosis , 1998, Neuron.
[184] Rena Li,et al. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain , 1997, Brain Research.
[185] H. McMahon,et al. Clathrin interacts specifically with amphiphysin and is displaced by dynamin 1 , 1997, FEBS letters.
[186] A. Tokunaga,et al. cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. , 1997, Biochemical and biophysical research communications.
[187] Nick C Fox,et al. Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation , 1996, The Lancet.
[188] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[189] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[190] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[191] B. Winblad,et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.
[192] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[193] Steven A. Johnson,et al. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat , 1990, Neuron.
[194] D. Pollen,et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.
[195] O. Wirths,et al. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer’s Disease , 2015, Molecular Neurobiology.
[196] Y. Liu,et al. Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.
[197] Keith A. Vossel,et al. Tau reduction prevents A-induced axonal transport deficits by blocking activation of GSK 3 , 2015 .
[198] Hao Wang,et al. TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer’s disease in Han Chinese , 2013, Journal of Neural Transmission.
[199] L. Tan,et al. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[200] M. Barcikowska,et al. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients. , 2012, Journal of Alzheimer's disease : JAD.
[201] F. Jessen,et al. Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration. , 2011, Journal of Alzheimer's disease : JAD.
[202] Rivka Inzelberg,et al. Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. , 2011, Journal of Alzheimer's disease : JAD.
[203] David B Goldstein,et al. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[204] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[205] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[206] S. Cichon,et al. Bmc Medical Genomics a Genome-wide Association Study for Late-onset Alzheimer's Disease Using Dna Pooling , 2008 .
[207] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .